Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GEOMC is a South Korean medical device company specializing in advanced non-invasive pain management technologies. The company is the developer and manufacturer of Scrambler Therapy, a neuromodulation technology marketed globally under the brand name Calmare. This technology utilizes a proprietary algorithm to transform pain signals into 'non-pain' synthetic signals, effectively masking chronic and neuropathic pain without the use of drugs. GEOMC's solutions are primarily targeted at patients suffering from treatment-resistant conditions such as chemotherapy-induced peripheral neuropathy and chronic cancer pain. The company maintains a presence in the global healthcare market, providing drug-free alternatives for pain relief in clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GEOMC.